Сравните лучших врачей по Эвиплера и цены в Турция. Найдите свой лучший вариант здесь.
Мы подберём лучших врачей исходя из ваших потребностей и бюджета.
Медицинский редактор Фахад Мавлюд
Медицинский редактор, Data ScientistЛучшие врачи
3
Турция
Отзывы
14000+
От реальных пациентов
Сравните цены на Эвиплера в лучших странах
Нажмите на страну, чтобы посмотреть лучших врачей и цены
Получите бесплатные персональные варианты лечения и выберите лучший. Без обязательств · Без оплаты наших услуг
Доктор Далкилич специализируется на лечении запущенных ХОБЛ и эмфиземы, проводя диагностическую и интервенционную бронхоскопию в больнице «Хисар Интерконтинентал».
Доцент кафедры инфекционных болезней, проводящий исследования в Медицинской школе Йельского университета – сосредоточен на разработке вакцин против болезней, передающихся клещами.
Проф. д-р Али Инал специализируется на клинической иммунологии и аллергологии, имеет опыт работы более 25 лет и занимается сложными иммунными ответами в Стамбульской больнице Университета Башкент.
Выбрать клинику за границей может быть непросто. Команда Bookimed помогла уже более чем 800 тысячам пациентов и понимает ваши опасения. Мы знаем, как найти надежных врачей, варианты с лучшим соотношением цены-качества и решения даже для сложных случаев. Мы готовы поддержать вас на каждом этапе этого пути.
Ян Мациевский
Руководитель команды врачей-координаторов
Более 4300+ успешных историй пациентов
3 лет работы в Bookimed
278 пациентов из Turkey нашли врача через нас в этом месяце
Опрос 2 минуты
Расскажите нам о цели, бюджете, сроках
Человек + ИИ
Наш алгоритм находит варианты, координатор проверяет соответствие
Варианты готовы
Сравнивайте цены, пакеты, даты. Общайтесь с координатором
Трудно выбрать?
Сопровождает лечение
Медицински подготовленные личные координаторы
| Рейтинг | Доктор | опыт | Подходит для | Что отличает их от других | Месторасположение клиники | Консультация |
|---|---|---|---|---|---|---|
| #1 | 35 лет опыта | Запущенная стадия ХОБЛ и эмфиземы | Специализируется на диагностической и интервенционной бронхоскопии при ХОБЛ и эмфиземе. Является экспертом в области нарушений сна и рака легких. | Турция | Цена по запросу | |
| #2 | 15 лет опыта | Болезни, передающиеся клещами | Исследования в Медицинской школе Йельского университета по вакцинам против болезней, передающихся клещами. Доцент кафедры инфекционных болезней с клиническим и исследовательским опытом. | Турция | Цена по запросу | |
| #3 | 26 лет опыта | Сложные иммунологические состояния | Специализируется на цитокиновых штормах и трансплантационной иммунологии, а также имеет руководящий опыт в иммунологических лабораториях. Отмечен за научные исследования и академический вклад. | Турция | Цена по запросу |
Eviplera is a single-tablet antiretroviral medication combining rilpivirine, emtricitabine, and tenofovir disoproxil to treat HIV-1. It works by blocking the reverse transcriptase enzyme, which prevents the virus from replicating and infecting new cells, effectively lowering the viral load in the bloodstream.
Bookimed Expert Insight: While Eviplera is highly effective, its rilpivirine component has a lower barrier to resistance than newer integrase inhibitors. Patients in Turkey often work with specialists like Associate Professor Husrev Diktas at Medipol Acibadem, who prioritize resistance genotyping before starting this specific regimen to ensure long-term success.
Patient Consensus: Many patients report vivid dreams or insomnia during the first month, though these effects typically fade. Consistency is vital, as missing doses with this specific drug combination significantly increases the risk of treatment resistance.
Commencing or switching to Eviplera in Turkey is safe when managed by infectious disease specialists at JCI-accredited facilities. While widely available in major pharmacies, non-citizens must pay out-of-pocket, with prices ranging from $900 to $1,400. Patients require a local prescription and baseline viral load monitoring.
Bookimed Expert Insight: While Eviplera costs $900 in Turkey, saving up to 76% vs US prices, the real advantage is the concentration of Yale-trained specialists in Istanbul. Associate Professor Husrev Diktas, who researched immunology at Yale, provides world-class oversight for complex medication switches.
Patient Consensus: Patients emphasize the importance of taking Eviplera with a full meal. They recommend visiting an HIV clinic first to secure a Turkish prescription and ensure pharmacy stock is available.
Starting Eviplera in Turkey requires mandatory diagnostic screenings to ensure patient safety and drug efficacy. Standard protocols involve HIV-1 RNA viral load testing, resistance profiling, and comprehensive organ function assessments. These tests verify the virus is susceptible to the medication and your body can process the treatment safely.
Bookimed Expert Insight: Turkish infectious disease specialists sometimes include TB screening (Quantiferon) as a routine pre-ART requirement. This is more rigorous than standard Western European protocols. Clinics like Emsey Hospital often coordinate these specific diagnostic panels within 24–48 hours to prevent delays in starting therapy.
Patient Consensus: Many patients suggest requesting a full Ministry of Health-compliant test list early. Fasting for lipid panels is often required and can cause unexpected delays if you are unprepared.
Specific medical conditions and drug interactions make Eviplera unsuitable for certain patients. Key exclusions include individuals with a viral load exceeding 100,000 copies/mL or known resistance to NNRTI medications. Patients with severe kidney or liver impairment and those under 18 years old should avoid this treatment.
Bookimed Expert Insight: HIV management in Turkey often involves highly specialized researchers like Associate Professor Husrev Diktas at Medipol Acibadem. He previously conducted vaccine research at Yale School of Medicine. This academic background ensures precise screening for complex contraindications that general practitioners might overlook.
Patient Consensus: Patients emphasize the need for thorough renal function testing before starting treatment. Experts suggest specialized screenings for neuropsychiatric history are essential to ensure the medication is safe for you.
Eviplera commonly causes gastrointestinal upset, dizziness, and sleep disturbances during the initial months of treatment. Patients must monitor for serious but rare complications like lactic acidosis and liver dysfunction. Regular bloodwork is required in clinics to track kidney health and metabolic changes effectively.
Bookimed Expert Insight: While side effects are a concern, specialist clinics in Istanbul like Emsey Hospital offer multidisciplinary support. Some patients manage initial stomach upset by using a bland diet and probiotics. Infectious disease experts like Associate Professor Husrev Diktas at Medipol Acibadem provide specialized HIV management to mitigate these risks.
Patient Consensus: Many reports highlight intense fatigue and mood swings in the first few months. However, several patients successfully maintain high energy levels and transition to zero side effects after their bodies adjust.
The standard follow-up schedule for Eviplera in Turkey includes a primary clinical assessment at 2 to 4 weeks to monitor renal function and drug tolerance. Stable patients transition to periodic laboratory checks every 3 to 6 months to evaluate viral load suppression and CD4 T-cell counts.
Bookimed Expert Insight: While European protocols are standard, selecting a specialist like Associate Professor Husrev Diktas at Medipol Acibadem District Hospital ensures access to Yale-trained expertise in HIV management. High-volume centers in Istanbul often provide faster laboratory results than rural state facilities, which is critical during the first month of treatment.
Patient Consensus: Many patients suggest tracking daily side effects like insomnia to discuss during the first month check-up. Those in large cities report faster access to viral load testing, while others emphasize strict adherence to the once-daily mealtime dosing.
Starting Eviplera therapy in Turkey requires a stay of 3 to 7 days. This period allows for a specialist consultation at a JCI-accredited facility, comprehensive baseline blood work, and monitoring for immediate side effects. Most patients initiate treatment within 24 to 72 hours of arrival.
Bookimed Expert Insight: While many expect immediate starts, arriving on a Tuesday or Wednesday is highly recommended. Our data shows that weekend laboratory closures in cities like Istanbul can unexpectedly add 2 days to your timeline. Securing a mid-week appointment ensures you receive results and the physical prescription without administrative delays.
Patient Consensus: Experienced travelers suggest budgeting for 1 or 2 extra hotel nights. They advise confirming the local pharmacy has the specific brand in stock before your flight to avoid logistical stress.